Neuronetics, Inc. 8-K

What Happened

• Neuronetics, Inc. filed a Form 8-K on June 23, 2026 announcing the Board promoted Cory Anderson from Senior Vice President, Chief Technology Officer to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026.
• Mr. Anderson, age 49, has 25+ years of medical device industry experience and held multiple R&D and clinical leadership roles at Neuronetics since 2021. The filing notes no family relationships or related-party transactions requiring disclosure.

Key Details

• Promotion effective date: July 1, 2026.
• New base salary: $425,000 per year.
• New target discretionary annual cash bonus: 45% of base salary.
• Continues to be eligible for annual equity grants under the company’s long-term incentive program.
• Background: former SVP R&D & Clinical and CTO roles at Neuronetics; prior roles at Sebacia, The Innovation Factory, Accuitive Medical Ventures, and Novoste; holds Bachelor’s and Master’s degrees in Biomedical Engineering (Tulane) and an MBA (Emory); inventor on seven U.S. patents.

Why It Matters

• This is an executive leadership change (Item 5.02) that updates management responsibilities and compensation. Investors should note the promotion may signal executive focus on the Greenbrook business unit and continued investment in R&D/clinical leadership.
• The filing discloses concrete compensation changes (salary and bonus target) and confirms continued equity participation and standard executive agreements, which are relevant to governance and potential dilution considerations.